Page last updated: 2024-10-23

azathioprine and Becker Muscular Dystrophy

azathioprine has been researched along with Becker Muscular Dystrophy in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Reggio, A1
Spada, F1
Rosina, M1
Massacci, G1
Zuccotti, A1
Fuoco, C1
Gargioli, C1
Castagnoli, L1
Cesareni, G1

Other Studies

1 other study available for azathioprine and Becker Muscular Dystrophy

ArticleYear
The immunosuppressant drug azathioprine restrains adipogenesis of muscle Fibro/Adipogenic Progenitors from dystrophic mice by affecting AKT signaling.
    Scientific reports, 2019, 03-13, Volume: 9, Issue:1

    Topics: Adipogenesis; Animals; Azathioprine; Cell Differentiation; Cells, Cultured; Disease Models, Animal;

2019